Beáta Horváth

571 total citations
19 papers, 447 citations indexed

About

Beáta Horváth is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Beáta Horváth has authored 19 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Beáta Horváth's work include Blood properties and coagulation (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Beáta Horváth is often cited by papers focused on Blood properties and coagulation (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Beáta Horváth collaborates with scholars based in Hungary, United States and Sweden. Beáta Horváth's co-authors include Kálmán Tóth, Gábor Késmárky, Tamás Alexy, Zsolt Márton, Katalin Koltai, Gergely Fehér, Tamás Habon, László Szapáry, Róbert Halmosi and I. Juricskay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Toxicology and Applied Pharmacology and Phytomedicine.

In The Last Decade

Beáta Horváth

19 papers receiving 430 citations

Peers

Beáta Horváth
Chiara Bencini Italy
Xiujuan Li China
Ian Birchall Australia
Xia Yin China
Masanori Iwase Japan
Füsun Erdenen Türkiye
Seyed Mostafa Shid Moosavi Iran
D. Lang United Kingdom
Kai Zeng China
Chiara Bencini Italy
Beáta Horváth
Citations per year, relative to Beáta Horváth Beáta Horváth (= 1×) peers Chiara Bencini

Countries citing papers authored by Beáta Horváth

Since Specialization
Citations

This map shows the geographic impact of Beáta Horváth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beáta Horváth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beáta Horváth more than expected).

Fields of papers citing papers by Beáta Horváth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beáta Horváth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beáta Horváth. The network helps show where Beáta Horváth may publish in the future.

Co-authorship network of co-authors of Beáta Horváth

This figure shows the co-authorship network connecting the top 25 collaborators of Beáta Horváth. A scholar is included among the top collaborators of Beáta Horváth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beáta Horváth. Beáta Horváth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bergman, Peter, Csaba Ádori, Szilvia Vas, et al.. (2014). Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proceedings of the National Academy of Sciences. 111(35). E3735–44. 63 indexed citations
2.
Fehér, Gergely, Katalin Koltai, Gábor Késmárky, et al.. (2009). Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. Phytomedicine. 16(2-3). 111–117. 8 indexed citations
3.
4.
Szapáry, László, Beáta Horváth, Zsolt Márton, et al.. (2008). Effect of atorvastatin treatment on the hemorheological and hemostaseological parameters in chronic cerebrovascular patients. Orvosi Hetilap. 149(24). 1117–1123. 3 indexed citations
5.
Koltai, Katalin, Gergely Fehér, P. Kenyeres, et al.. (2008). Relation of platelet aggregation and fibrinogen levels to advancing age in aspirin- and thienopyridine-treated patients. Clinical Hemorheology and Microcirculation. 40(4). 295–302. 8 indexed citations
6.
Papp, Előd, Viktória Havasi, Judit Bene, et al.. (2007). Does Glycoprotein IIIa Gene (PlA) Polymorphism Influence Clopidogrel Resistance?. Drugs & Aging. 24(4). 345–350. 7 indexed citations
7.
Késmárky, Gábor, Gergely Fehér, Katalin Koltai, Beáta Horváth, & Kálmán Tóth. (2006). Viscosity, hemostasis and inflammation in atherosclerotic heart diseases.. PubMed. 35(1-2). 67–73. 36 indexed citations
8.
Papp, Előd, Viktória Havasi, Judit Bene, et al.. (2005). Glycoprotein IIIA Gene (PIA) Polymorphism and Aspirin Resistance: Is There Any Correlation?. Annals of Pharmacotherapy. 39(6). 1013–1018. 50 indexed citations
9.
Alexy, Tamás, Ambrus Tóth, Zsolt Márton, et al.. (2004). Inhibition of ADP-Evoked Platelet Aggregation by Selected Poly(ADP-Ribose) Polymerase Inhibitors. Journal of Cardiovascular Pharmacology. 43(3). 423–431. 10 indexed citations
10.
11.
Horváth, Beáta, László Szapáry, Zsolt Márton, et al.. (2004). Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases.. PubMed. 9(1). 31–4. 66 indexed citations
12.
Márton, Zsolt, Róbert Halmosi, Tamás Alexy, et al.. (2004). Hemorheological methods in drug research.. PubMed. 30(3-4). 243–52. 2 indexed citations
13.
Szapáry, László, Beáta Horváth, Tamás Alexy, et al.. (2003). [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].. PubMed. 144(20). 973–8. 5 indexed citations
14.
Horváth, Beáta, László Szapáry, Zsolt Márton, et al.. (2003). [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].. PubMed. 144(50). 2471–6. 2 indexed citations
15.
Szapáry, László, Mónika Szőts, Beáta Horváth, et al.. (2003). [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].. PubMed. 144(22). 1085–90. 3 indexed citations
16.
Horváth, Beáta, Zsolt Márton, Róbert Halmosi, et al.. (2002). In Vitro Antioxidant Properties of Pentoxifylline, Piracetam, and Vinpocetine. Clinical Neuropharmacology. 25(1). 37–42. 83 indexed citations
17.
Horváth, Beáta, Zsolt Márton, Róbert Halmosi, et al.. (2002). [Scavenger effect of various cerebrovascular drugs].. PubMed. 143(1). 13–7. 1 indexed citations
18.
Márton, Zsolt, Róbert Halmosi, Beáta Horváth, et al.. (2001). Scavenger Effect of Experimental and Clinically Used Cardiovascular Drugs. Journal of Cardiovascular Pharmacology. 38(5). 745–753. 27 indexed citations
19.
Young, Duncan, et al.. (1976). 1,4-Dioxane and β-hydroxyethoxyacetic acid excretion in urine of humans exposed to dioxane vapors. Toxicology and Applied Pharmacology. 38(3). 643–646. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Bencini Breakdown of academic impact, for papers by Xiujuan Li Breakdown of academic impact, for papers by Ian Birchall Breakdown of academic impact, for papers by Xia Yin Breakdown of academic impact, for papers by Masanori Iwase Breakdown of academic impact, for papers by Füsun Erdenen Breakdown of academic impact, for papers by Seyed Mostafa Shid Moosavi Breakdown of academic impact, for papers by D. Lang Breakdown of academic impact, for papers by Kai Zeng
Rankless by CCL
2026